NCT00684580 Protocol For Collecting Data On Patients With Childhood Cancer
| NCT ID | NCT00684580 |
| Status | Recruiting |
| Phase | — |
| Sponsor | St. Jude Children's Research Hospital |
| Condition | Childhood Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 30,000 participants |
| Start Date | 2000-06-08 |
| Primary Completion | 2045-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30,000 participants in total. It began in 2000-06-08 with a primary completion date of 2045-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Progress in the development of curative therapy for pediatric malignancies has resulted in increasing numbers of long-term childhood cancer survivors. This protocol is a means to provide continuing review of outcome and late toxicity for all patients actively being treated and previously treated for childhood cancer at St. Jude Children's Research Hospital.
Eligibility Criteria
Inclusion Criteria: * All St Jude patients actively being followed or treated for childhood cancer Exclusion Criteria: * St. Jude consult only patients * St. Jude patients permanently discharged from care and follow-up Permanently discharged patients include patients who have electively transferred their oncologic care to another institution, those who are noncompliant with recommended follow-up or those leaving the institution against medical advice. * Patients referred to St. Jude for limited care on phase 1 protocol.
Contact & Investigator
Melissa M Hudson, MD
PRINCIPAL INVESTIGATOR
St. Jude Children's Research Hospital
Frequently Asked Questions
Who can join the NCT00684580 clinical trial?
This trial is open to participants of all sexes, studying Childhood Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00684580 currently recruiting?
Yes, NCT00684580 is actively recruiting participants. Contact the research team at referralinfo@stjude.org for enrollment information.
Where is the NCT00684580 trial being conducted?
This trial is being conducted at Memphis, United States.
Who is sponsoring the NCT00684580 clinical trial?
NCT00684580 is sponsored by St. Jude Children's Research Hospital. The principal investigator is Melissa M Hudson, MD at St. Jude Children's Research Hospital. The trial plans to enroll 30,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.